Nesprin 1 and 2 in cardiac structure, function, and disease
Nesprin 1 and 2 in cardiac structure, function, and disease
批准号:
8061320
负责人:
Ju Chen
金额:
$38.63万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2015-11-30
关键词:
AblationAddressAdultAge-MonthsAllelesAnimalsBindingBiological ProcessBody WeightC-terminalCardiacCardiac MyocytesCardiomyopathiesCell NucleusCellsDataDefectDesminDilated CardiomyopathyDiseaseEmery-Dreifuss Muscular DystrophyExerciseFamilyGene DeletionGoalsHeartIntermediate FilamentsInvestigationKnock-outKnockout MiceLamin Type AMembraneMembrane ProteinsMicrofilamentsMolecularMusMuscleMuscle FibersMuscle functionMutant Strains MiceMutationMyocardiumN-terminalNuclearNuclear EnvelopeNuclear Outer MembraneNuclear StructureOrganismPathogenesisPeptidesPerinatalPhenotypePhysiologicalPositioning AttributeProtaminesProteinsRelative (related person)RoleSamplingShapesSkeletal MuscleSpectrinStretchingStructureSurvivorsSynapsesTamoxifenTestingUp-Regulationcalponinimprovedinsightloss of functionmembermuscular structuremutantnovelpapillary muscleresearch studyresponseretinal rods
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Mutations in the outer nuclear membrane proteins Nesprin 1 and 2 may be involved in the pathogenesis of Emery-Dreifuss muscular dystrophy (EDMD)-like phenotypes, including cardiomyopathy and dilated cardiomyopathy (DCM). Nesprins belong to a newly discovered family of spectrin-repeat proteins, composed of four members. Nesprin 1 and 2 are believed to anchor nuclei to actin filaments, and are ubiquitously expressed. To investigate functions of Nesprin 1 and 2, we have generated floxed and global knockout mice of both Nesprin 1 and 2. Our studies reveal that Nesprin 2 global knockout mice are viable and have no obvious basal phenotype, whereas over half of Nesprin 1 global knockout (Nesprin 1-/-) mice die perinatally. Remaining Nesprin 1-/- survivors have reduced body weight before three months of age and compromised exercise capacity. Consistent with data from others, we have found 100% perinatal lethality in double knockout mice for Nesprin 1 and 2. Histological analyses of skeletal muscle in Nesprin 1-/- mice and Nesprin 1 and 2 double knockout mice revealed abnormal positioning of non-synaptic nuclei and the disappearance of clusters of synaptic nuclei. We also observed that Nesprin 1-/- mice display abnormal shape and positioning of cardiomyocyte nuclei. In addition, we observed upregulation of protein levels of SUN1, a Nesprin 1 binding partner and an inner nuclear membrane protein, in Nesprin 1-/- heart samples. This 5 year proposal is to investigate the role of Nesprin 1 and 2 in cardiac nuclear position, nuclear membrane structure, and cardiac function by analysis of mutant mice and cells derived from them. Our unique ability to genetically ablate Nesprins in mouse cardiomyocytes, combined with the ability to test molecular and physiological functions in the whole animal, isolated papillary muscles, and cultured cardiomyocytes, will provide novel information as to the function of Nesprins in cardiac structure, function and disease.
PUBLIC HEALTH RELEVANCE:
Recent data suggest that mutations in Nesprin 1 and 2 may be involved in the pathogenesis of Emery-Dreifuss muscular dystrophy (EDMD)-like phenotypes including cardiomyopathy and dilated cardiomyopathy (DCM). Our proposed studies will help us to understand biological functions of Nesprin 1 and 2 in cardiac structure and function. The proposed studies will also help us gain insight into mechanisms by which mutations in Nesprin 1 are involved in the pathogenesis of DCM, thereby improving our general understanding of DCM.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ATF4 a Novel Regulator of Cardiac Development
-
批准号:10657081
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2023
-
负责人:Ju Chen
-
依托单位:
Novel function of a mitochondria phosphatase in cardiac development
-
批准号:10436945
-
项目类别:
-
资助金额:$54.57万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Protein Kinase Novel 2 (PKN2) in heart
-
批准号:10322445
-
项目类别:
-
资助金额:$54.7万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Nuclear envelope protein LEMD2 in heart
-
批准号:10278926
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Protein Kinase Novel 2 (PKN2) in heart
-
批准号:10548141
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Nuclear envelope protein LEMD2 in heart
-
批准号:10662287
-
项目类别:
-
资助金额:$53.9万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Nuclear envelope protein LEMD2 in heart
-
批准号:10463758
-
项目类别:
-
资助金额:$54.61万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Novel function of a mitochondria phosphatase in cardiac development
-
批准号:10687847
-
项目类别:
-
资助金额:$53.91万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
Novel function of a mitochondria phosphatase in cardiac development
-
批准号:10181409
-
项目类别:
-
资助金额:$55.3万
-
财政年份:2021
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10025986
-
项目类别:
-
资助金额:$39.38万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10242912
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10615837
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
PRDM16 in cardiac development
-
批准号:10414087
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2020
-
负责人:Ju Chen
-
依托单位:
ALPK3 in cardiac function and disease
-
批准号:10360581
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2019
-
负责人:Ju Chen
-
依托单位:
The Cardiac Role of Filamin C
-
批准号:10322727
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2019
-
负责人:Ju Chen
-
依托单位:
The role of Nexilin in cardiomyocyte and cardiomyopathy
-
批准号:9925817
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2017
-
负责人:Ju Chen
-
依托单位:
Adipocytes and cardiac remodeling
-
批准号:9010674
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Ju Chen
-
依托单位:
Adipocytes and cardiac remodeling
-
批准号:9198055
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2015
-
负责人:Ju Chen
-
依托单位:
Luma in Cardiac Function and Disease
-
批准号:8748180
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:Ju Chen
-
依托单位:
Luma in Cardiac Function and Disease
-
批准号:8894593
-
项目类别:
-
资助金额:$38.17万
-
财政年份:2014
-
负责人:Ju Chen
-
依托单位:
海外基金